These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6841525)

  • 21. Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localisation and effects of peptidase inhibitors.
    Llorens-Cortes C; Gros C; Schwartz JC
    Eur J Pharmacol; 1985 Dec; 119(3):183-91. PubMed ID: 3912194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human brain leucyl aminopeptidase: isolation, characterization and specificity against some neuropeptides.
    Gibson AM; Biggins JA; Lauffart B; Mantle D; McDermott JR
    Neuropeptides; 1991 Jul; 19(3):163-8. PubMed ID: 1680222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of glycation on the chemical and enzymatic stability of the endogenous opioid peptide, leucine-enkephalin, and related fragments.
    Jakas A; Horvat S
    Bioorg Chem; 2004 Dec; 32(6):516-26. PubMed ID: 15530992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of an enkephalin-hydrolyzing dipeptidyl-aminopeptidase from calf-brain striatum.
    van Buuren KJ; van Amsterdam JG; Mulder JR; Soudijn W
    Neuropeptides; 1985 Sep; 6(5):381-9. PubMed ID: 3903539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide transport system-1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for either.
    Maresh GA; Kastin AJ; Brown TT; Zadina JE; Banks WA
    Brain Res; 1999 Aug; 839(2):336-40. PubMed ID: 10519058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification to homogeneity of an active opioid receptor from rat brain by affinity chromatography.
    Loukas S; Mercouris M; Panetsos F; Zioudrou C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4574-8. PubMed ID: 8183950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refinement of conformational preferences of Leu enkephalin and Tyr-Gly-Gly-Phe by 15N n.m.r.: chemical shifts and vicinal coupling constants.
    Garbay-Jaureguiberry C; Marion D; Fellion E; Roques BP
    Int J Pept Protein Res; 1982 Nov; 20(5):443-50. PubMed ID: 7174208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin.
    Bernkop-Schnürch A; Obermair K; Greimel A; Palmberger TF
    Amino Acids; 2006 Jun; 30(4):417-23. PubMed ID: 16554973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrolysis of various bioactive peptides by goat brain dipeptidylpeptidase-III homologue.
    Dhanda S; Singh J; Singh H
    Cell Biochem Funct; 2008 Apr; 26(3):339-45. PubMed ID: 18064728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transformations of bioactive peptides in the presence of sugars--characterization and stability studies of the adducts generated via the Maillard reaction.
    Roscić M; Horvat S
    Bioorg Med Chem; 2006 Jul; 14(14):4933-43. PubMed ID: 16563774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal 4-imidazolidinone prodrugs of Leu-enkephalin: synthesis, chemical and enzymatic stability studies.
    Bak A; Fich M; Larsen BD; Frokjaer S; Friis GJ
    Eur J Pharm Sci; 1999 Mar; 7(4):317-23. PubMed ID: 9971915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of differentiation on the leucine enkephalin-degrading soluble enzymes released by the K562(S) cell line.
    Marini M; Bongiorno L; Urbani A; Trani E; Roda LG
    Neurochem Res; 1997 Dec; 22(12):1415-23. PubMed ID: 9357005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion and inactivation of opioid peptides by rabbit brain endo-oligopeptidase A.
    Camargo AC; Ribeiro MJ; Schwartz WN
    Biochem Biophys Res Commun; 1985 Jul; 130(2):932-8. PubMed ID: 2992491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrolysis of leucine enkephalin in the nasal cavity of the rat--a possible factor in the low bioavailability of nasally administered peptides.
    Hussain A; Faraj J; Aramaki Y; Truelove JE
    Biochem Biophys Res Commun; 1985 Dec; 133(3):923-8. PubMed ID: 4084310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new fluorogenic assay for tyrosine-containing peptides.
    Tellier M; Prankerd RJ; Hochhaus G
    J Pharm Biomed Anal; 1991; 9(7):557-63. PubMed ID: 1817676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-performance liquid chromatographic determination of leucine-enkephalin-like peptide in rat brain by pre-column fluorescence derivatization involving formylation followed by reaction with 1,2-diamino-4,5-dimethoxybenzene.
    Kai M; Ishida J; Ohkura Y
    J Chromatogr; 1988 Sep; 430(2):271-8. PubMed ID: 3235503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-dimensional high-performance liquid chromatography of opioid peptides following pre-column derivatization with naphthalene-2,3-dicarboxaldehyde in the presence of cyanide ion. Preliminary results on the determination of leucine- and methionine-enkephalin-like fluorescence in the striatum region of the rat brain.
    Mifune M; Krehbiel DK; Stobaugh JF; Riley CM
    J Chromatogr; 1989 Nov; 496(1):55-70. PubMed ID: 2592517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.